3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Multiple Myeloma
73
Precursor Cell Lymphoblastic Leukemia-Lymphoma
28
Burkitt Lymphoma
25
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
11
Recurrence
8
Immunoglobulin Light-chain Amyloidosis
8
Vomiting
7
Nausea
7
Lymphoma, Mantle-Cell
7
Leukemia, Biphenotypic, Acute
7
Lymphoma, Large B-Cell, Diffuse
6
Lymphoma
6
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
5
Neoplasms
5
Lymphoma, Non-Hodgkin
5
Leukemia, Myeloid, Acute
5
Leukemia
5
Hodgkin Disease
5
Smoldering Multiple Myeloma
4
Neoplasms, Plasma Cell
4
Neoplasm Metastasis
4
Breast Neoplasms
4
Blast Crisis
4
Prostatic Neoplasms
3
Plasmacytoma
3
Ovarian Neoplasms
3
Myelodysplastic Syndromes
3
Lymphoma, Follicular
3
Lymphoma, B-Cell, Marginal Zone
3
Lung Neoplasms
3
Interventions
dexamethasone acetate
1
dexamethasone 21-phosphate
1
Etoricoxib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Somatoform Disorders
×
dexamethasone acetate
×
Clear all
NCT03348696
2020-01-09
REaCT-TAPS
Ottawa Hospital Research Institute
Phase 4
Completed
124 enrolled